Ampio Pharm Stock Net Income
| AMPE Stock | USD 0.26 0.25 2,500% |
As of the 2nd of February, Ampio Pharm shows the Mean Deviation of 993.49, downside deviation of 81.29, and Risk Adjusted Performance of 0.2515. Ampio Pharm technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Ampio Pharm jensen alpha, as well as the relationship between the potential upside and skewness to decide if Ampio Pharm is priced correctly, providing market reflects its regular price of 0.26 per share. As Ampio Pharm appears to be a penny stock we also recommend to validate its total risk alpha numbers.
Ampio Pharm's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Ampio Pharm's valuation are provided below:Ampio Pharm does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Ampio |
Ampio Pharm 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ampio Pharm's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ampio Pharm.
| 11/04/2025 |
| 02/02/2026 |
If you would invest 0.00 in Ampio Pharm on November 4, 2025 and sell it all today you would earn a total of 0.00 from holding Ampio Pharm or generate 0.0% return on investment in Ampio Pharm over 90 days. Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for t... More
Ampio Pharm Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ampio Pharm's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ampio Pharm upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 81.29 | |||
| Information Ratio | 0.3338 | |||
| Maximum Drawdown | 9998.31 | |||
| Value At Risk | (96.30) | |||
| Potential Upside | 3974.07 |
Ampio Pharm Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ampio Pharm's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ampio Pharm's standard deviation. In reality, there are many statistical measures that can use Ampio Pharm historical prices to predict the future Ampio Pharm's volatility.| Risk Adjusted Performance | 0.2515 | |||
| Jensen Alpha | 563.68 | |||
| Total Risk Alpha | 484.95 | |||
| Sortino Ratio | 6.97 | |||
| Treynor Ratio | 5.97 |
Ampio Pharm February 2, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2515 | |||
| Market Risk Adjusted Performance | 5.98 | |||
| Mean Deviation | 993.49 | |||
| Semi Deviation | 49.57 | |||
| Downside Deviation | 81.29 | |||
| Coefficient Of Variation | 299.51 | |||
| Standard Deviation | 1698.26 | |||
| Variance | 2884080.09 | |||
| Information Ratio | 0.3338 | |||
| Jensen Alpha | 563.68 | |||
| Total Risk Alpha | 484.95 | |||
| Sortino Ratio | 6.97 | |||
| Treynor Ratio | 5.97 | |||
| Maximum Drawdown | 9998.31 | |||
| Value At Risk | (96.30) | |||
| Potential Upside | 3974.07 | |||
| Downside Variance | 6608.73 | |||
| Semi Variance | 2457.44 | |||
| Expected Short fall | (2,130) | |||
| Skewness | 3.62 | |||
| Kurtosis | 14.96 |
Ampio Pharm Backtested Returns
Ampio Pharm is out of control given 3 months investment horizon. Ampio Pharm secures Sharpe Ratio (or Efficiency) of 0.33, which signifies that the company had a 0.33 % return per unit of risk over the last 3 months. We were able to interpolate data for thirty different technical indicators, which can help you to evaluate if expected returns of 104.05% are justified by taking the suggested risk. Use Ampio Pharm Risk Adjusted Performance of 0.2515, downside deviation of 81.29, and Mean Deviation of 993.49 to evaluate company specific risk that cannot be diversified away. Ampio Pharm holds a performance score of 26 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 95.0, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ampio Pharm will likely underperform. Use Ampio Pharm sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to analyze future returns on Ampio Pharm.
Auto-correlation | 0.08 |
Virtually no predictability
Ampio Pharm has virtually no predictability. Overlapping area represents the amount of predictability between Ampio Pharm time series from 4th of November 2025 to 19th of December 2025 and 19th of December 2025 to 2nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ampio Pharm price movement. The serial correlation of 0.08 indicates that barely 8.0% of current Ampio Pharm price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.08 | |
| Spearman Rank Test | 0.14 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Ampio Pharm reported net income of (8.63 Million). This is 102.53% lower than that of the Pharmaceuticals sector and 112.32% lower than that of the Health Care industry. The net income for all United States stocks is 101.51% higher than that of the company.
Ampio Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ampio Pharm's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Ampio Pharm could also be used in its relative valuation, which is a method of valuing Ampio Pharm by comparing valuation metrics of similar companies.Ampio Pharm is currently under evaluation in net income category among its peers.
Ampio Fundamentals
| Return On Equity | -1.14 | |||
| Return On Asset | -0.62 | |||
| Current Valuation | (3.33 M) | |||
| Shares Outstanding | 1.14 M | |||
| Shares Owned By Insiders | 1.56 % | |||
| Shares Owned By Institutions | 4.19 % | |||
| Number Of Shares Shorted | 32.9 K | |||
| Price To Earning | 28.57 X | |||
| Price To Book | 0.21 X | |||
| EBITDA | (8.63 M) | |||
| Net Income | (8.63 M) | |||
| Cash And Equivalents | 23.25 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 274 K | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 4.85 X | |||
| Book Value Per Share | 4.03 X | |||
| Cash Flow From Operations | (8.56 M) | |||
| Short Ratio | 0.31 X | |||
| Earnings Per Share | (10.66) X | |||
| Target Price | 2.0 | |||
| Beta | 1.95 | |||
| Market Capitalization | 340.61 K | |||
| Total Asset | 5.74 M | |||
| Retained Earnings | (242.53 M) | |||
| Working Capital | 3.36 M | |||
| Current Asset | 29.23 M | |||
| Current Liabilities | 5.52 M | |||
| Net Asset | 5.74 M |
About Ampio Pharm Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ampio Pharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ampio Pharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ampio Pharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Ampio Pink Sheet
Ampio Pharm financial ratios help investors to determine whether Ampio Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ampio with respect to the benefits of owning Ampio Pharm security.